Rate My Professor Suzie Lavoie

Lavoie's research centers on youth mental health, leveraging neuroscience and EEG to identify biomarkers such as mismatch negativity and erythrocyte glutathione levels that predict transition to psychosis in ultra-high risk individuals. Her expertise includes psychopathology, neuroimaging, reactive oxygen species, neuropsychiatry, clinical assessment, adolescent psychiatry, clinical psychiatry, and psychopharmacology. Key publications encompass "Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients" (2008), "Erythrocyte glutathione levels as long-term predictor of transition to psychosis" (2017), "Impaired mismatch negativity to frequency deviants in individuals at ultra-high risk for psychosis" (2017), "Harmonised collection of data in youth mental health: Towards large datasets" (2020), and "The electroencephalography protocol for the Accelerating Medicines Partnership Schizophrenia Program: Reliability and stability of measures" (2025). With over 70 publications and approximately 2,950 citations, her contributions extend to major initiatives including the NEURAPRO trial, PRESCIENT network, and Accelerating Medicines Partnership Schizophrenia program, advancing prediction models, clinical staging, neurophenomenology of basic self-disturbance, and early intervention strategies.